Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Michael Horsman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Physiology

Cell Hypoxia

Chemicals & Drugs

Procedures

Phenomena

Partial Pressure

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
70
Overgaard, Jens
15
Nordsmark, Marianne
13
Murata, Rumi
12
Maxwell, Ross
12
Siemann, Dietmar
11
Alsner, Jan
9
Stødkilde-Jørgensen, Hans
6
Bentzen, Lise
5
Keiding, Susanne
5
Nielsen, Flemming
3
van der Kogel, Albert
3
Workman, Paul
3
Sørensen, Brita
3
Lindegaard, Jacob Christian
3
Pedersen, Michael

Sign-in to see all Coauthors

Publications

TOP 3
Busk Morten; Horsman Michael R; Jakobsen Steen; Hansen Kim V; Bussink Johan; van der Kogel Albert; Overgaard Jens
Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?
Sørensen Brita Singers; Horsman Michael R; Vorum Henrik; Honoré Bent; Overgaard Jens; Alsner Jan
Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics.
Siemann Dietmar W; Horsman Michael R
Vascular targeted therapies in oncology.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Michael Horsman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Busk Morten; Horsman Michael R; Jakobsen Steen; Hansen Kim V; Bussink Johan; van der Kogel Albert; Overgaard Jens
Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast?
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):429-36.
2009: Sørensen Brita Singers; Horsman Michael R; Vorum Henrik; Honoré Bent; Overgaard Jens; Alsner Jan
Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):443-9.
2009: Siemann Dietmar W; Horsman Michael R
Vascular targeted therapies in oncology.
Cell and tissue research 2009;335(1):241-8.
2008: Murata Rumi; Tsujitani Michihiko; Horsman Michael R
Enhanced local tumour control after single or fractionated radiation treatment using the hypoxic cell radiosensitizer doranidazole.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2008;87(3):331-8.
2008: Busk Morten; Horsman Michael R; Kristjansen Paul E G; van der Kogel Albert J; Bussink Johan; Overgaard Jens
Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia.
International journal of cancer. Journal international du cancer 2008;122(12):2726-34.
2008: Busk Morten; Horsman Michael R; Jakobsen Steen; Keiding Susanne; van der Kogel Albert J; Bussink Johan; Overgaard Jens
Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy.
International journal of radiation oncology, biology, physics 2008;70(4):1202-12.
2008: Nielsen Thomas; Murata Rumi; Maxwell Ross J; Stødkilde-Jørgensen Hans; Ostergaard Leif; Horsman Michael R
Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients.
International journal of radiation oncology, biology, physics 2008;70(3):859-66.
2008: Horsman Michael R
Angiogenesis and vascular targeting: relevance for hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2008;24(1):57-65.
2008: Chen Gang; Horsman Michael R; Pedersen Michael; Pang Qi; Stødkilde-Jørgensen Hans
The effect of combretastatin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumours.
Acta oncologica (Stockholm, Sweden) 2008;47(6):1071-6.
2008: Nielsen Thomas; Mouridsen Kim; Maxwell Ross J; Stødkilde-Jørgensen Hans; Østergaard Leif; Horsman Michael R
Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
Acta oncologica (Stockholm, Sweden) 2008;47(7):1265-70.
2008: Busk Morten; Horsman Michael R; Overgaard Jens
Resolution in PET hypoxia imaging: voxel size matters.
Acta oncologica (Stockholm, Sweden) 2008;47(7):1201-10.
2008: Lukacova Slavka; Sørensen Brita S; Alsner Jan; Overgaard Jens; Horsman Michael R
The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models.
Acta oncologica (Stockholm, Sweden) 2008;47(5):941-7.
2007: Hokland S L; Horsman M R
The new vascular disrupting agent combretastatin-A1-disodium-phosphate (OXi4503) enhances tumour response to mild hyperthermia and thermoradiosensitization.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2007;23(7):599-606.
2007: Horsman M R; Overgaard J
Hyperthermia: a potent enhancer of radiotherapy.
Clinical oncology (Royal College of Radiologists (Great Britain)) 2007;19(6):418-26.
2007: Sørensen Brita Singers; Alsner Jan; Overgaard Jens; Horsman Michael R
Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):362-6.
2007: Nordsmark Marianne; Eriksen Jesper Grau; Gebski Val; Alsner Jan; Horsman Michael R; Overgaard Jens
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2007;83(3):389-97.
2006: Horsman Michael R; Siemann Dietmar W
Pathophysiologic effects of vascular-targeting agents and the implications for combination with conventional therapies.
Cancer research 2006;66(24):11520-39.
2006: Eriksen Jesper Grau; Horsman Michael R
Tumour hypoxia - a characteristic feature with a complex molecular background.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;81(2):119-21.
2006: Lukacova Slavka; Overgaard Jens; Alsner Jan; Horsman Michael R
Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental models.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):165-71.
2006: Chaplin David J; Horsman Michael R; Siemann Dietmar W
Current development status of small-molecule vascular disrupting agents.
Current opinion in investigational drugs (London, England : 2000) 2006;7(6):522-8.
2006: Horsman Michael R
Tissue physiology and the response to heat.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2006;22(3):197-203.
2006: Horsman Michael R; Bohm Lothar; Margison Geoffrey P; Milas Luka; Rosier Jean-Francois; Safrany Geza; Selzer Edgar; Verheij Marcel; Hendry Jolyon H
Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting.
International journal of radiation oncology, biology, physics 2006;64(2):551-61.
2006: Horsman Michael R; Nielsen Thomas; Østergaard Leif; Overgaard Jens
Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
Acta oncologica (Stockholm, Sweden) 2006;45(7):876-80.
2006: Breidahl Tomas; Nielsen Flemming U; Stødkilde-Jørgensen Hans; Maxwell Ross J; Horsman Michael R
The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: a comparative assessment using MRI and MRS.
Acta oncologica (Stockholm, Sweden) 2006;45(3):306-16.
2005: Lukacova Slavka; Khalil Azza A; Overgaard Jens; Alsner Jan; Horsman Michael R
Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum.
International journal of radiation biology 2005;81(12):937-44.
2005: Overgaard Jens; Eriksen Jesper Grau; Nordsmark Marianne; Alsner Jan; Horsman Michael R;
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.
The lancet oncology 2005;6(10):757-64.
2005: Chen Gang; Jespersen Sune; Pedersen Michael; Pang Qi; Horsman Michael R; Stødkilde Jørgensen Hans
Evaluation of anti-vascular therapy with texture analysis.
Anticancer research 2005;25(5):3399-405.
2005: Sørensen Brita Singers; Hao Jing; Overgaard Jens; Vorum Henrik; Honoré Bent; Alsner Jan; Horsman Michael R
Influence of oxygen concentration and pH on expression of hypoxia induced genes.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2005;76(2):187-93.
2005: Sørensen Michael; Horsman Michael R; Cumming Paul; Munk Ole Lajord; Keiding Susanne
Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
International journal of radiation oncology, biology, physics 2005;62(3):854-61.
2005: Chen Gang; Jespersen Sune Nørhøj; Pedersen Michael; Pang Qi; Horsman Michael R; Stødkilde-Jørgensen Hans
Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant.
Magnetic resonance imaging 2005;23(5):685-9.
2005: Leach M O; Brindle K M; Evelhoch J L; Griffiths J R; Horsman M R; Jackson A; Jayson G C; Judson I R; Knopp M V; Maxwell R J; McIntyre D; Padhani A R; Price P; Rathbone R; Rustin G J; Tofts P S; Tozer G M; Vennart W; Waterton J C; Williams S R; Workman P;
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations.
British journal of cancer 2005;92(9):1599-610.
2005: Bentzen Lise; Vestergaard-Poulsen Peter; Nielsen Thomas; Overgaard Jens; Bjørnerud Atle; Briley-Saebø Karen; Horsman Michael R; Ostergaard Leif
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor.
International journal of radiation oncology, biology, physics 2005;61(4):1208-15.
2005: Siemann Dietmar W; Bibby Michael C; Dark Graham G; Dicker Adam P; Eskens Ferry A L M; Horsman Michael R; Marmé Dieter; Lorusso Patricia M
Differentiation and definition of vascular-targeted therapies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):416-20.
2004: Murata R; Horsman M R
Tumour-specific enhancement of thermoradiotherapy at mild temperatures by the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2004;20(4):393-404.
2004: Siemann Dietmar W; Chaplin David J; Horsman Michael R
Vascular-targeting therapies for treatment of malignant disease.
Cancer 2004;100(12):2491-9.
2004: Siemann Dietmar W; Horsman Michael R
Targeting the tumor vasculature: a strategy to improve radiation therapy.
Expert review of anticancer therapy 2004;4(2):321-7.
2004: Grönroos Tove; Bentzen Lise; Marjamäki Päivi; Murata Rumi; Horsman Michael R; Keiding Susanne; Eskola Olli; Haaparanta Merja; Minn Heikki; Solin Olof
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
European journal of nuclear medicine and molecular imaging 2004;31(4):513-20.
2004: Horsman Michael R; Overgaard Jens
Preclinical studies on how to deal with patient intolerance to nicotinamide and carbogen.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2004;70(3):301-9.
2003: Horsman Michael R; Murata Rumi
Vascular targeting effects of ZD6126 in a C3H mouse mammary carcinoma and the enhancement of radiation response.
International journal of radiation oncology, biology, physics 2003;57(4):1047-55.
2002: Horsman Michael R; Murata Rumi
Combination of vascular targeting agents with thermal or radiation therapy.
International journal of radiation oncology, biology, physics 2002;54(5):1518-23.
2002: Offersen B V; Knap M M; Marcussen N; Horsman M R; Hamilton-Dutoit S; Overgaard J
Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis.
British journal of cancer 2002;87(12):1422-30.
2002: Siemann Dietmar W; Horsman Michael R
Enhancement of radiation therapy by vascular targeting agents.
Current opinion in investigational drugs (London, England : 2000) 2002;3(11):1660-5.
2002: Bentzen Lise; Keiding Susanne; Horsman Michael R; Grönroos Tove; Hansen Søren B; Overgaard Jens
Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing.
Acta oncologica (Stockholm, Sweden) 2002;41(3):304-12.
2001: Murata R; Overgaard J; Horsman M R
Potentiation of the anti-tumour effect of hyperthermia by combining with the vascular targeting agent 5,6-dimethylxanthenone-4-acetic acid.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 2001;17(6):508-19.
2001: Murata R; Overgaard J; Horsman M R
Combretastatin A-4 disodium phosphate: a vascular targeting agent that improves that improves the anti-tumor effects of hyperthermia, radiation, and mild thermoradiotherapy.
International journal of radiation oncology, biology, physics 2001;51(4):1018-24.
2001: Murata R; Siemann D W; Overgaard J; Horsman M R
Improved tumor response by combining radiation and the vascular-damaging drug 5,6-dimethylxanthenone-4-acetic acid.
Radiation research 2001;156(5 Pt 1):503-9.
2001: Murata R; Siemann D W; Overgaard J; Horsman M R
Interaction between combretastatin A-4 disodium phosphate and radiation in murine tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2001;60(2):155-61.
2001: Nielsen F U; Daugaard P; Bentzen L; Stødkilde-Jørgensen H; Overgaard J; Horsman M R; Maxwell R J
Effect of changing tumor oxygenation on glycolytic metabolism in a murine C3H mammary carcinoma assessed by in vivo nuclear magnetic resonance spectroscopy.
Cancer research 2001;61(13):5318-25.
2001: Nordsmark M; Alsner J; Keller J; Nielsen O S; Jensen O M; Horsman M R; Overgaard J
Hypoxia in human soft tissue sarcomas: adverse impact on survival and no association with p53 mutations.
British journal of cancer 2001;84(8):1070-5.
2001: Murata R; Overgaard J; Horsman M R
Comparative effects of combretastatin A-4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on blood perfusion in a murine tumour and normal tissues.
International journal of radiation biology 2001;77(2):195-204.
2001: Horsman M R; Murata R; Overgaard J
Improving local tumor control by combining vascular targeting drugs, mild hyperthermia and radiation.
Acta oncologica (Stockholm, Sweden) 2001;40(4):497-503.
2000: Bentzen L; Horsman M R; Daugaard P; Maxwell R J
Non-invasive tumour blood perfusion measurement by 2H magnetic resonance.
NMR in biomedicine 2000;13(8):429-37.
2000: Siemann D W; Warrington K H; Horsman M R
Targeting tumor blood vessels: an adjuvant strategy for radiation therapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2000;57(1):5-12.
2000: Overgaard J; Alsner J; Eriksen J; Horsman M R; Grau C
Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck.
Rays 2000;25(3):313-9.
2000: Bentzen L; Keiding S; Horsman M R; Falborg L; Hansen S B; Overgaard J
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
Acta oncologica (Stockholm, Sweden) 2000;39(5):629-37.
2000: Horsman M R; Murata R; Breidahl T; Nielsen F U; Maxwell R J; Stødkiled-Jørgensen H; Overgaard J
Combretastatins novel vascular targeting drugs for improving anti-cancer therapy. Combretastatins and conventional therapy.
Advances in experimental medicine and biology 2000;476():311-23.
1999: Ehrnrooth E; von der Maase H; Sørensen B S; Poulsen J H; Horsman M R
The ability of hypoxia to modify the gene expression of thymidylate synthase in tumour cells in vivo.
International journal of radiation biology 1999;75(7):885-91.
1999: Nielsen F U; Topp S; Horsman M R; Overgaard J; Stødkilde-Jørgensen H; Maxwell R J
Localized in vivo 1H NMR spectroscopy of murine tumours: effect of blood flow reduction.
NMR in biomedicine 1999;12(4):175-83.
1998: Horsman M R; Nordsmark M; Overgaard J
Techniques to assess the oxygenation of human tumors. State of the art.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 1998;174 Suppl 4():2-5.
1998: Horsman M R; Ehrnrooth E; Ladekarl M; Overgaard J
The effect of combretastatin A-4 disodium phosphate in a C3H mouse mammary carcinoma and a variety of murine spontaneous tumors.
International journal of radiation oncology, biology, physics 1998;42(4):895-8.
1998: Maxwell R J; Nielsen F U; Breidahl T; Stødkilde-Jørgensen H; Horsman M R
Effects of combretastatin on murine tumours monitored by 31P MRS, 1H MRS and 1H MRI.
International journal of radiation oncology, biology, physics 1998;42(4):891-4.
1998: Horsman M R
Measurement of tumor oxygenation.
International journal of radiation oncology, biology, physics 1998;42(4):701-4.
1998: Siemann D W; Johansen I M; Horsman M R
Radiobiological hypoxia in the KHT sarcoma: predictions using the Eppendorf histograph.
International journal of radiation oncology, biology, physics 1998;40(5):1171-6.
1998: Horsman M R; Alsner J; Overgaard J
The effect of shark cartilage extracts on the growth and metastatic spread of the SCCVII carcinoma.
Acta oncologica (Stockholm, Sweden) 1998;37(5):441-5.
1998: Aboagye E O; Maxwell R J; Horsman M R; Lewis A D; Workman P; Tracy M; Griffiths J R
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.
British journal of cancer 1998;77(1):65-70.
1997: Horsman M R; Siemann D W; Chaplin D J; Overgaard J
Nicotinamide as a radiosensitizer in tumours and normal tissues: the importance of drug dose and timing.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1997;45(2):167-74.
1997: Aboagye E O; Maxwell R J; Kelson A B; Tracy M; Lewis A D; Graham M A; Horsman M R; Griffiths J R; Workman P
Preclinical evaluation of the fluorinated 2-nitroimidazole N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR-4554) as a probe for the measurement of tumor hypoxia.
Cancer research 1997;57(15):3314-8.
1997: Horsman M R; Overgaard J
Can mild hyperthermia improve tumour oxygenation?
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1997;13(2):141-7.
1997: Nordsmark M; Maxwell R J; Horsman M R; Bentzen S M; Overgaard J
The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.
British journal of cancer 1997;76(11):1432-9.
1996: Horsman M R; Sampson L E; Chaplin D J; Overgaard J
The in vivo interaction between flavone acetic acid and hyperthermia.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1996;12(6):779-89.
1996: Nordsmark M; Maxwell R J; Wood P J; Stratford I J; Adams G E; Overgaard J; Horsman M R
Effect of hydralazine in spontaneous tumours assessed by oxygen electrodes and 31P-magnetic resonance spectroscopy.
The British journal of cancer. Supplement 1996;27():S232-5.
1996: Horsman M R; Chaplin D J; Hill S A; Arnold S; Collingridge D; Radacic M; Wood P J; Overgaard J
Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
The British journal of cancer. Supplement 1996;27():S168-71.
1996: Wood P J; Horsman M R; Khalil A A; Steinberg F; Streffer C; Overgaard J; Stratford I J; Adams G E
A comparison of the physiological effects of RSU1069 and RB6145 in the SCCVII murine tumour.
Acta oncologica (Stockholm, Sweden) 1996;35(8):989-94.
1995: Horsman M R; Nordsmark M; Høyer M; Overgaard J
Direct evidence that hydralazine can induce hypoxia in both transplanted and spontaneous murine tumours.
British journal of cancer 1995;72(6):1474-8.
1995: Lynch E M; Sampson L E; Khalil A A; Horsman M R; Chaplin D J
Cytotoxic effect of tumour necrosis factor -alpha on sarcoma F cells at tumour relevant oxygen tensions.
Acta oncologica (Stockholm, Sweden) 1995;34(3):423-7.
1995: Nordsmark M; Grau C; Horsman M R; Jörgensen H S; Overgaard J
Relationship between tumour oxygenation, bioenergetic status and radiobiological hypoxia in an experimental model.
Acta oncologica (Stockholm, Sweden) 1995;34(3):329-34.
1995: Horsman M R; Grau C; Overgaard J
Reoxygenation in a C3H mouse mammary carcinoma. The importance of chronic rather than acute hypoxia.
Acta oncologica (Stockholm, Sweden) 1995;34(3):325-8.
1995: Khalil A A; Horsman M R; Overgaard J
The importance of determining necrotic fraction when studying the effect of tumour volume on tissue oxygenation.
Acta oncologica (Stockholm, Sweden) 1995;34(3):297-300.
1995: Horsman M R
Nicotinamide and other benzamide analogs as agents for overcoming hypoxic cell radiation resistance in tumours. A review.
Acta oncologica (Stockholm, Sweden) 1995;34(5):571-87.
1995: Horsman M R; Khalil A A; Chaplin D J; Overgaard J
The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma.
Acta oncologica (Stockholm, Sweden) 1995;34(3):443-6.
1994: Horsman M R; Christensen K L; Overgaard J
Importance of nicotinamide dose on blood pressure changes in mice and humans.
International journal of radiation oncology, biology, physics 1994;29(3):455-8.
1994: Grau C; Nordsmark M; Khalil A A; Horsman M R; Overgaard J
Effect of carbon monoxide breathing on hypoxia and radiation response in the SCCVII tumor in vivo.
International journal of radiation oncology, biology, physics 1994;29(3):449-54.
1994: Horsman M R; Khalil A A; Siemann D W; Grau C; Hill S A; Lynch E M; Chaplin D J; Overgaard J
Relationship between radiobiological hypoxia in tumors and electrode measurements of tumor oxygenation.
International journal of radiation oncology, biology, physics 1994;29(3):439-42.
1994: Horsman M R; Chaplin D J
Enhancement of cyclophosphamide cytotoxicity in vivo by the benzamide analogue pyrazinamide.
British journal of cancer 1994;69(4):648-54.
1994: Grau C; Khalil A A; Nordsmark M; Horsman M R; Overgaard J
The relationship between carbon monoxide breathing, tumour oxygenation and local tumour control in the C3H mammary carcinoma in vivo.
British journal of cancer 1994;69(1):50-7.
1994: Horsman M R; Khalil A A; Nordsmark M; Grau C; Overgaard J
Measurement of pO2 in a murine tumour and its correlation with hypoxic fraction.
Advances in experimental medicine and biology 1994;345():493-500.
1994: Horsman M R; Nordsmark M; Khalil A; Chaplin D J; Overgaard J
Tumour radiosensitization by nicotinamide: is it the result of an improvement in tumour oxygenation?
Advances in experimental medicine and biology 1994;345():403-9.
1994: Horsman M R; Nordsmark M; Khalil A A; Hill S A; Chaplin D J; Siemann D W; Overgaard J
Reducing acute and chronic hypoxia in tumours by combining nicotinamide with carbogen breathing.
Acta oncologica (Stockholm, Sweden) 1994;33(4):371-6.
1994: Horsman M R; Siemann D W; Nordsmark M; Khalil A A; Overgaard J; Chaplin D J
The combination of nicotinamide and carbogen breathing to improve tumour oxygenation prior to radiation treatment.
Advances in experimental medicine and biology 1994;361():635-42.
1993: Overgaard J; Radacic M; Skaric D; Skaric V; Horsman M R; Lindegaard J C; Jercic J
Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1993;9(6):821-30.
1993: Horsman M R; Khalil A A; Nordsmark M; Grau C; Overgaard J
Relationship between radiobiological hypoxia and direct estimates of tumour oxygenation in a mouse tumour model.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;28(1):69-71.
1993: Horsman M R; Høyer M; Honess D J; Dennis I F; Overgaard J
Nicotinamide pharmacokinetics in humans and mice: a comparative assessment and the implications for radiotherapy.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1993;27(2):131-9.
1993: Radacic M; Overgaard J; Skaric D; Skaric V; Horsman M
Reduction of cisplatinum-induced renal toxicity in mice by tetrahydroindazolonecarboxylic acid (HIDA) [corrected]
Acta oncologica (Stockholm, Sweden) 1993;32(1):53-6.
1992: Horsman M R; Overgaard J
BW12C-induced changes in haemoglobin-oxygen affinity in mice and its influence on the radiation response of a C3H mouse mammary carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1992;25(1):43-8.
1992: Horsman M R; Christensen K L; Overgaard J
Relationship between the hydralazine-induced changes in murine tumor blood supply and mouse blood pressure.
International journal of radiation oncology, biology, physics 1992;22(3):455-8.
1992: Grau C; Horsman M R; Overgaard J
Influence of carboxyhemoglobin level on tumor growth, blood flow, and radiation response in an experimental model.
International journal of radiation oncology, biology, physics 1992;22(3):421-4.
1992: Grau C; Horsman M R; Overgaard J
Improving the radiation response in a C3H mouse mammary carcinoma by normobaric oxygen or carbogen breathing.
International journal of radiation oncology, biology, physics 1992;22(3):415-9.
1992: Lindegaard J C; Radacic M; Khalil A A; Horsman M R; Overgaard J
Cisplatin and hyperthermia treatment of a C3H mammary carcinoma in vivo. Importance of sequence, interval, drug dose, and temperature.
Acta oncologica (Stockholm, Sweden) 1992;31(3):347-51.
1992: Horsman M R; Kristjansen P E; Mizuno M; Christensen K L; Chaplin D J; Quistorff B; Overgaard J
Biochemical and physiological changes induced by nicotinamide in a C3H mouse mammary carcinoma and CDF1 mice.
International journal of radiation oncology, biology, physics 1992;22(3):451-4.
1991: Overgaard J; Grau C; Lindegaard J C; Horsman M R
The potential of using hyperthermia to eliminate radioresistant hypoxic cells.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20 Suppl 1():113-6.
1991: Fisker R V; Horsman M R; Overgaard J
Hydralazine-induced changes in tissue perfusion and radiation response in a C3H mammary carcinoma and mouse normal tissues.
Acta oncologica (Stockholm, Sweden) 1991;30(5):641-7.
1991: Horsman M R; Chaplin D J; Overgaard J
The use of blood flow modifiers to improve the treatment response of solid tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1991;20 Suppl 1():47-52.
1990: Horsman M R; Chaplin D J; Overgaard J
Combination of nicotinamide and hyperthermia to eliminate radioresistant chronically and acutely hypoxic tumor cells.
Cancer research 1990;50(23):7430-6.
1990: Christensen K L; Horsman M R; Overgaard J
Invasive blood pressure measurements in restrained but non-anaesthetized mice.
In vivo (Athens, Greece) 1990;4(1):13-6.
1989: Horsman M R; Hansen P V; Overgaard J
Radiosensitization by nicotinamide in tumors and normal tissues: the importance of tissue oxygenation status.
International journal of radiation oncology, biology, physics 1989;16(5):1273-6.
1989: Horsman M R; Christensen K L; Overgaard J
Hydralazine-induced enhancement of hyperthermic damage in a C3H mammary carcinoma in vivo.
International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 1989;5(2):123-36.
1989: Horsman M R; Winther J
Vascular effects of photodynamic therapy in an intraocular retinoblastoma-like tumour.
Acta oncologica (Stockholm, Sweden) 1989;28(5):693-7.
1989: Horsman M R; Overgaard J; Christensen K L; Trotter M J; Chaplin D J
Mechanism for the reduction of tumour hypoxia by nicotinamide and the clinical relevance for radiotherapy.
Biomedica biochimica acta 1989;48(2-3):S251-4.

Sign-in to see more